首页> 美国卫生研究院文献>Journal of Virus Eradication >Highlights from the Third Biennial Strategies for an HIV Cure Meeting
【2h】

Highlights from the Third Biennial Strategies for an HIV Cure Meeting

机译:艾滋病治疗会议第三次双年度战略的重点

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Since the first Strategies for an HIV Cure Meeting organised by the National Institute of Allergy and Infectious Diseases (NIAID) in 2012, one of the primary purposes of the meeting has been to facilitate communication and foster collaboration across the NIAID-funded Martin Delaney Collaboratories for HIV cure research (MDC), the broader HIV cure-related research field, and industry and community stakeholders. This year's meeting agenda reflected NIAID's increasing investment over the last 5 years in research to identify strategies for eradicating or achieving long-term remission of HIV infection. Overviews and research highlights were presented from each of the Martin Delaney Collaboratories, as well as projects funded through the Beyond HAART programme, the Consortia for Innovative AIDS Research in Nonhuman Primates (CIAR) programme, the ACTG and IMPAACT clinical trial networks, and the NIAID Vaccine Research Center in hopes of stimulating cross-talk and synergy among these and other programmes focused on HIV cure research. Aside from the oral presentations described here, the meeting also included 75 poster presentations. Finally, community engagement activities and community participation in the MDC was highlighted throughout the first day and in a special session on Day 2. This reflects NIAID's commitment to engage community partners in the earliest stages of research towards curative interventions through the MDC programme. The entire meeting is available for viewing via the NIH VideoCast website at: .
机译:自2012年美国国家过敏和传染病研究所(NIAID)举办首次艾滋病毒治疗策略会议以来,会议的主要目的之一是促进NIAID资助的马丁·德莱尼(Martin Delaney)协作组织之间的沟通和合作。 HIV治疗研究(MDC),与HIV治疗相关的更广泛的研究领域以及行业和社区利益相关者。今年的会议议程反映了NIAID在过去5年中对研究的不断增加的投资,以确定用于消除或实现艾滋病毒感染的长期缓解的策略。马丁·德莱尼(Martin Delaney)合作伙伴以及由Beyond HAART计划,非人类灵长类动物创新艾滋病研究联盟(CIAR)计划,ACTG和IMPAACT临床试验网络以及NIAID资助的项目介绍了概述和研究重点。疫苗研究中心希望在这些和其他针对HIV治愈研究的计划之间激发相声和协同作用。除了此处介绍的口头报告外,会议还包括75个海报演示。最后,在第一天和第二天的一次特别会议上强调了社区参与活动和社区对MDC的参与。这反映了NIAID致力于通过MDC计划在早期研究阶段让社区合作伙伴参与治疗干预的承诺。可以通过NIH VideoCast网站(网址为)观看整个会议。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号